已收盘 05-15 16:00:00 美东时间
-3.710
-4.99%
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Nektar Therapeutics (($NKTR)) has held its Q1 earnings call. Read on for the ma...
05-09 08:51
Nektar Therapeutics ( ($NKTR) ) has issued an update. On May 8, 2026, Nektar Th...
05-09 06:21
Piper Sandler analyst Yasmeen Rahimi maintains Nektar Therapeutics (NASDAQ:NKTR) with a Overweight and raises the price target from $105 to $192.
05-08 23:09
华盛资讯5月8日讯,内克塔治疗公布2026财年Q1业绩,公司Q1营收0.11亿美元,同比增长3.8%,归母净利润亏损0.45亿美元,同比亏损缩窄11.7%。
05-08 07:17
AEVEX Corp (NYSE:AVEX) shares are trading higher on Thursday as traders keep leaning into the post-IPO momentum in a high-volatility phase.
04-23 22:48
U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas Instruments April 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CME Group, GE Vernova and Texas Instruments on Thursday. HIGHLIGHTS * CME Group Inc CME.O : JP Morga
04-23 15:46
今日重点评级关注:HC Wainwright & Co.:维持Century Therapeutics"买入"评级,目标价从2美元升至5美元;Oppenheimer:维持Climb Bio"跑赢大市"评级,目标价从10美元升至18美元
04-22 12:41
美联储新主席呼之欲出?沃什今夜十点将出席提名听证会;“大空头”再唱空!伯里称科技巨头盈利被高估逾4成;联合健康盘前大涨7%,公司计划Q2回购20亿美元股份>>
04-21 20:13